JUN 02, 2016 08:15 AM PDT

Diagnosing Rare Newborn Diseases with New Genetic Sequencing

WRITTEN BY: Kara Marker
For newborns in neonatal intensive care units with rare and complex diseases that doctors do not come across on a regular basis, production of an accurate molecular diagnosis can take months or even years. For worried parents, it can seem like a lifetime. A new study published in the Canadian Medial Association Journal offers a solution for infants and their families who are playing the waiting game, and it revolves around next-generation gene sequencing to deliver a diagnosis.
 
 
In a clinical trial with 20 newborns, each with a set of complicated medical issues, researchers tested a new genetic sequencing protocol that includes a panel of all 4183 genes known to be associated with all rare diseases known to medicine. Over half of the newborns had neurological symptoms, including chronic seizures and hypotonia, a state of “floppiness.” Medline Plus describes hypotonia like this:
“Infants with normal tone can be lifted with the adult's hands placed under the armpits. Hypotonic infants tend to slip between the hands as the infant's arms rise without resistance.”
 
For about 40 percent of the infants presenting with complex symptoms, the new sequencing technique led to a molecular diagnosis. For two infants, the molecular diagnosis made by the experimental gene sequencing technique had a substantial impact on how their doctors approached their medical treatment.
 
"This technique can be performed in a hospital-based laboratory without the need to send samples away, often out of the country," states Dr. David Dyment. "This will allow for diagnoses to be made quickly, providing answers to anxious families and potentially life-saving interventions in some cases."
 
The current method of diagnosing newborns with these symptoms involves conducting several tests, looking for specific gene mutations or abnormal expression levels. The new system that tests 4183 genes known to indicate disease greatly accelerates the diagnosis process, leading to quicker onset of an appropriate treatment plan, and ultimately better health outcomes for the infant.
 
“It can also indicate whether other family members may be at risk of the same disease and provide an accurate recurrence risk for future pregnancies,” Dyment pointed out.
 
It is important for doctors who want to successfully implement this system of genetic sequencing in the detection of rare and complex newborn diseases to communicate effectively with local neonatologists, intensive care physicians, and genetics laboratories. Successfully executing this technology now offers the “potential to transform the practice of clinical genetics,” Dyment claims.
 
 
Sources: Canadian Medical Association Journal, MedlinePlus
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 20, 2019
Technology
OCT 20, 2019
App Offers Assessment for Multiple Sclerosis
Scientists at Johns Hopkins Medical School have reported on a new tablet-based app development concerned assessing cognitive function in a fast and accurat...
OCT 20, 2019
Microbiology
OCT 20, 2019
A Quick Squirt of Sanitizer May Not be Enough to Protect Against the Flu
Alcohol-based hand sanitizers are thought to provide protection from pathogens that spread in saliva and mucus. But is that true?...
OCT 20, 2019
Genetics & Genomics
OCT 20, 2019
Can Autism be Diagnosed from Blood Tests?
Diagnosing Autism Spectrum Disorder (ASD) early on in life through behavioral signs alone has been difficult. This comes as typical markers for the conditi...
OCT 20, 2019
Health & Medicine
OCT 20, 2019
Emissions From Cannabis Growing Facilities Could Impact Air Quality
New research from the Desert Research Institute (DRI) and the Washoe County Health District (WCHD) shows that the same chemicals that are responsible for t...
OCT 20, 2019
Microbiology
OCT 20, 2019
Molecule in Human Breast Milk Can Fight Microbial Pathogens
Now a team of scientists has found a molecule in human breast milk that may reduce the risk of illness and disease....
OCT 20, 2019
Clinical & Molecular DX
OCT 20, 2019
AcroMetrix BCR-ABL External Molecular Panel: An Accurate Testing Method for Chronic Myeloid Leukemia
To support the validation and verification of new assays in oncology testing, Thermo Fisher Scientific with AcroMetrix control products provides innov...
Loading Comments...